IL6 and Miyoshi myopathy: Treatment with IMiDs significantly abrogates the interaction between MM cells and BMSCs by decreasing the production of IL-6 by stromal cells and downregulating adhesion molecules including LFA-1/ICAM-1 and VLA-4/VCAM-1 (269).